ARVEESpecialty Chemicals
Arvee Laboratories India Ltd — Cash Flow Statement
₹133.86
-4.98%
Arvee Laboratories India Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 1.08 Cr | 1.44 Cr | -1.68 Cr | -0.58 Cr |
| Issuance Of Debt | 0.00 | — | — | 5.01 Cr |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure | -2.59 Cr | -1.48 Cr | -2.36 Cr | -2.29 Cr |
| End Cash Position | 1.85 Cr | 0.54 Cr | 1.28 Cr | 6.61 Cr |
| Other Cash Adjustment Outside Changein Cash | -20.00 | -20.00 | -10.00 | -2.00 |
| Beginning Cash Position | 0.54 Cr | 1.28 Cr | 6.61 Cr | 0.98 Cr |
| Changes In Cash | 1.31 Cr | -0.75 Cr | -5.32 Cr | 5.63 Cr |
| Financing Cash Flow | -0.19 Cr | -2.42 Cr | -6.06 Cr | 4.52 Cr |
| Interest Paid Cff | -0.19 Cr | -0.29 Cr | -0.31 Cr | -0.49 Cr |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | 0.00 | -2.13 Cr | -5.75 Cr | 5.01 Cr |
| Net Short Term Debt Issuance | 0.00 | -2.13 Cr | -5.75 Cr | 5.01 Cr |
| Short Term Debt Issuance | 0.00 | — | — | 5.01 Cr |
| Net Long Term Debt Issuance | 0.00 | -2.13 Cr | -5.75 Cr | 5.01 Cr |
| Investing Cash Flow | -2.16 Cr | -1.26 Cr | 0.06 Cr | -0.60 Cr |
| Net Other Investing Changes | 0.06 Cr | 83000.00 | -10.00 | -1.00 |
| Interest Received Cfi | 0.36 Cr | 0.20 Cr | 0.27 Cr | 0.28 Cr |
| Net Investment Purchase And Sale | 0.06 Cr | 83260.00 | 2.16 Cr | 1.36 Cr |
| Sale Of Investment | 0.06 Cr | 83260.00 | 2.16 Cr | 1.36 Cr |
| Purchase Of Investment | 0.00 | 0.00 | — | — |
| Net PPE Purchase And Sale | -2.59 Cr | -1.47 Cr | -2.36 Cr | -2.24 Cr |
| Sale Of PPE | 0.00 | 0.02 Cr | 0.00 | 0.05 Cr |
| Purchase Of PPE | -2.59 Cr | -1.48 Cr | -2.36 Cr | -2.29 Cr |
| Operating Cash Flow | 3.66 Cr | 2.93 Cr | 0.68 Cr | 1.71 Cr |
| Taxes Refund Paid | -0.43 Cr | -1.75 Cr | -0.95 Cr | -0.96 Cr |
| Change In Working Capital | 1.00 Cr | -3.64 Cr | -4.13 Cr | -3.37 Cr |
| Change In Other Current Liabilities | 0.01 Cr | 0.00 | 0.00 | 0.00 |
| Change In Other Current Assets | 0.05 Cr | 0.00 | 0.00 | 0.00 |
| Change In Payable | -1.89 Cr | -2.28 Cr | 0.88 Cr | -0.27 Cr |
| Change In Inventory | -1.83 Cr | 1.16 Cr | 1.70 Cr | -0.96 Cr |
| Change In Receivables | 4.71 Cr | -2.52 Cr | -6.72 Cr | -2.14 Cr |
| Other Non Cash Items | -0.17 Cr | 0.08 Cr | 0.05 Cr | 0.21 Cr |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation And Amortization | 1.50 Cr | 2.08 Cr | 2.38 Cr | 2.47 Cr |
| Amortization Cash Flow | 91520.00 | 98000.00 | 0.07 Cr | 0.07 Cr |
| Depreciation | 1.49 Cr | 2.07 Cr | 2.31 Cr | 2.40 Cr |
| Gain Loss On Investment Securities | -0.06 Cr | -83260.00 | -0.12 Cr | -0.29 Cr |
| Gain Loss On Sale Of PPE | 0.00 | -10050.00 | 0.00 | 0.02 Cr |
| Net Income From Continuing Operations | 1.83 Cr | 6.17 Cr | 3.45 Cr | 3.64 Cr |
| Repayment Of Debt | — | -2.13 Cr | -5.75 Cr | 0.00 |
| Short Term Debt Payments | — | -2.13 Cr | -5.75 Cr | — |
| Long Term Debt Payments | — | -2.13 Cr | -5.75 Cr | 0.00 |
| Net Other Financing Charges | — | — | -1000.00 | — |
| Pension And Employee Benefit Expense | — | — | 0.00 | 0.00 |
| Long Term Debt Issuance | — | — | — | 5.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Arvee Laboratories India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.